33 results
424B3
PPBT
Purple Biotech Ltd
14 Nov 23
Prospectus supplement
4:13pm
in France and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s
F-1/A
PPBT
Purple Biotech Ltd
13 Nov 23
Registration statement (foreign) (amended)
4:11pm
and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s Vice President
F-1
PPBT
Purple Biotech Ltd
30 Oct 23
Registration statement (foreign)
4:30pm
and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s Vice President
6-K
EX-99.1
PPBT
Purple Biotech Ltd
1 May 23
Notice of Annual General Meeting of Shareholders
4:00pm
subsidize ongoing corporate governance or other professional training for directors in amounts up to US$5,000 per director per annum, and we reimburse
6-K
EX-99.1
0v4s4eukmg
18 Jul 22
Notice of Annual General Meeting of Shareholders
4:25pm
6-K
EX-99.1
srh2a 5nbt50ha4iqp
9 Dec 21
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer
7:30am
6-K
EX-99.1
934h 9tmzx
10 Nov 21
Notice of Annual General Meeting of Shareholders
4:45pm
20-F/A
br979x l40
16 Mar 21
Annual report (foreign) (amended)
3:22pm
6-K
EX-99.2
yn7pm547em5 lersw6w8
22 Oct 20
Notice of Annual General Meeting of Shareholders
4:10pm
424B4
8lyr75y4
16 Mar 20
Prospectus supplement with pricing info
6:08am
F-1/A
rk6yts2x4
11 Mar 20
Registration statement (foreign) (amended)
9:16am
F-1/A
lc7w67x8e9xh01uyqs6m
10 Mar 20
Registration statement (foreign) (amended)
8:13am
6-K
EX-99.1
a4exbgv6
11 Feb 20
Kitov Pharma Provides Corporate Update and Reports Full-Year 2019 Financial Results
7:01am
424B3
kkv nh735dr
27 Dec 19
Prospectus supplement
4:30pm
F-1
nhc kru10i92qai7gq
27 Dec 19
Registration statement (foreign)
4:09pm
6-K
EX-99.1
gfhpz3qg16
19 Nov 19
Report of Foreign Private Issuer
4:31pm